SCHEMBL24309360

SCHEMBL24309360

CC(C)c1ccccc1-c1nc(NSc2cccc(N)c2)nc(Cl)c1C(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.31
▸ TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310683 0.82 DHFR (0.31) DHFR
SCHEMBL24309696 0.81 HSP90AA1 (0.35) DHFRTRPA1
SCHEMBL24331090 0.79 USP1 (0.38) TRPA1
SCHEMBL24309791 0.78 AXL (0.33) —
SCHEMBL29567037 0.78 POLB (0.42) —
SCHEMBL24310681 0.78 POLB (0.42) —
SCHEMBL24309377 0.74 ADRA2A (0.30) —
SCHEMBL24309629 0.71 P2RX3 (0.33) DHFRTRPA1
SCHEMBL24310447 0.70 USP1 (0.33) —
SCHEMBL24309257 0.69 USP1 (0.33) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback